Evaluation of the potential carcinogenicity of chlornaphazine. Final report

Technical Report · Wed Jun 01 04:00:00 EDT 1988

OSTI ID:6521313

Chlornaphazine is a possible human carcinogen, classified as weight-of-evidence Group C under the EPA Guidelines for Carcinogen Risk Assessment (U.S. EPA, 1986a). Evidence on potential carcinogenicity from animal studies is Limited, and the evidence from human studies is Inadequate. Data available are inadequate for calculating a potency factor (F) and no quantitative inferences can be made according to the CAG's methodology for evaluating potential carcinogens (U.S. EPA, 1986b). Chlornaphazine is, therefore, assigned to the median potency factor range and placed in potency group 2. Combining the weight-of-evidence group and the potency group, chlornaphazine is assigned a LOW hazard ranking for the purposes of RQ adjustment.

• Research Organization: Syracuse Research Corp., NY (United States)
• OSTI ID: 6521313
• Report Number(s): PB-93-185239/XAB; CNN: EPA-68-03-3112; EPA-68-03-3182
• Country of Publication: United States
• Language: English

Related Subjects

29 ENERGY PLANNING, POLICY, AND ECONOMY
290300 -- Energy Planning & Policy-- Environment
Health
& Safety
560300* -- Chemicals Metabolism & Toxicology
63 RADIATION, THERMAL, AND OTHER ENVIRON. POLLUTANT EFFECTS ON LIVING ORGS. AND BIOL. MAT.
ANIMALS
CARCINOGENS
DATA PROCESSING
DOCUMENT TYPES
DOSE-RESPONSE RELATIONSHIPS
HAZARDOUS MATERIALS
HUMAN POPULATIONS
MATERIALS
NATIONAL ORGANIZATIONS
POPULATIONS
PROCESSING
QUANTIZATION
REGULATORY GUIDES
RISK ASSESSMENT
TASK SCHEDULING
TOXICITY
US EPA
US ORGANIZATIONS
WEIGHT